...

CJC-1295 NO DAC 5mg

$39.99

(5.0) (40 customer reviews)

Research Studies:

  • Potent GHRH receptor agonist for investigating selective somatotroph-mediated growth hormone signaling
  • Supports analysis of pulsatile growth hormone secretion in various cellular models
  • Enables research on cAMP-dependent protein kinase A activation and downstream transcription
  • Useful for evaluating the hypothalamic-pituitary-somatotropic axis without long-term albumin conjugation

Quantity:

Free Shipping
Buy Peptides with confidence: Stripe-powered secure checkout and major cards accepted.
Secure payment methods for buying peptides: Visa, MasterCard, AMEX, and more.
Buy Peptides with confidence: Stripe-powered secure checkout and major cards accepted.
Secure payment methods for buying peptides: Visa, MasterCard, AMEX, and more.

FREE Shipping on 

orders over $200

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.

Description

CJC-1295 No DAC 5mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.

Key Product Details

  • Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
  • Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
  • Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
  • Produced with lot-level traceability to support research documentation and laboratory recordkeeping.

Research Documentation Context

  • Supports compound characterization in controlled laboratory settings.
  • Provides batch-specific identity and purity documentation for research review.
  • Allows lot-level traceability across laboratory documentation workflows.
  • Supports comparison of product labeling, analytical documentation, and storage information during research planning.
  • Supports analytical review of peptide research materials within a strictly laboratory-focused context.

Specifications and Documentation

  • Certificate of Analysis: Available with batch-specific documentation where applicable.
  • Material Safety Data Sheet: Coming Soon.
  • Handling and Storage Instructions: Coming Soon.
  • Product Form: Lyophilized powder.
  • Purity Specification: ≥99% purity.
  • Intended Use: Laboratory research use only.

CJC-1295 No DAC 5mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.

Additional information

CAS No.

863288-34-0

Purity

≥99%

Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser

Molecular Formula

C152H252N44O42

Molecular Weight

3367.96 g/mol

Applications

Growth hormone secretion research, metabolic function studies, muscle growth and fat loss exploration.

Synthesis

Solid-phase synthesis

Format

Lyophilized powder

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months.

Appearance

White lyophilized powder

Shipping Conditions

Shipped at ambient temperature; once received, store at -20°C

Regulatory/Compliance

Manufactured in a facility that adheres to cGMP guidelines

There are no reviews yet.

We value your feedback. Please leave a review below:

Research Procurement Information

Buy CJC-1295 No DAC Online for Research | COA Guide

Researchers searching for buy CJC-1295 No DAC online should evaluate CJC-1295 No DAC as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, and storage information. This guide explains how to evaluate CJC-1295 No DAC for controlled research procurement through Pure Lab Peptides.

Fast Answer: buy CJC-1295 No DAC online

Researchers can buy CJC-1295 No DAC online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.

What Does “Buy CJC-1295 No DAC Online” Mean in a Research Context?

The phrase “buy CJC-1295 No DAC online” is addressed here as laboratory research procurement intent, not personal-use intent. In this context, the searcher is typically comparing RUO labeling, supplier transparency, batch-specific documentation, compound identity, purity data, and lot-level traceability before selecting a research material for controlled laboratory workflows.

Research-use-only sourcing is different from consumer-style buying. Qualified researchers and technical procurement teams should evaluate whether the supplier presents CJC-1295 No DAC as an RUO compound, whether a CJC-1295 No DAC COA is available, whether the product page avoids unsupported product-use claims, and whether the documentation aligns with the material received.

A procurement review should focus on records. Relevant records may include the certificate of analysis, product label, lot number, product form, stated purity, storage information, and analytical method notes. FDA guidance on RUO and investigational-use labeling in the in vitro diagnostic context illustrates the importance of aligning labeling with intended research use rather than diagnostic or consumer positioning [1].

CJC-1295 No DAC Research Material Overview

CJC-1295 No DAC is a synthetic peptide research material associated with growth hormone-releasing hormone analog literature. PubChem lists “CJC1295 Without DAC” as a compound record with formula C152H252N44O42, while PubChem lists “Cjc 1295” as a related record with a different formula, reflecting the importance of distinguishing product identity during procurement review [2] [3].

Published literature on CJC-1295 commonly discusses long-acting growth hormone-releasing hormone analog design and related receptor-pathway research. One early paper described CJC-1295 as an hGRF1-29-albumin bioconjugate designed for research on growth hormone-releasing factor receptor activity in rat pituitary models [4]. Because CJC-1295 No DAC is distinguished from DAC-containing CJC-1295 at the procurement level, researchers should review the exact product name, formula, and batch-specific documentation rather than assuming that every CJC-1295 citation describes the same material form.

The relevant pathway context is growth hormone-releasing hormone receptor research. Reviews and receptor summaries describe the GHRH receptor as a receptor involved in growth hormone-releasing hormone signaling, while UniProt database records identify human GHRHR and GHRH entries for sequence and protein-reference context [5] [6] [7] [8]. Pathway relevance in published literature does not establish product-use guidance for RUO materials.

Structural biology research has also examined activation of the growth hormone-releasing hormone receptor, providing model-level context for receptor studies rather than procurement or use instructions for RUO peptide materials [9]. For CJC-1295 No DAC research-use-only sourcing, the practical issue is not a biological outcome claim; it is whether the material can be identified, documented, traced, stored, and reviewed consistently.

Why Researchers Search “Buy CJC-1295 No DAC Online”

Researchers may search this phrase to determine whether an RUO supplier provides CJC-1295 No DAC research material with clear product labeling, purity documentation, supplier documentation, and batch-specific COA access. A laboratory buyer may also need to verify that the compound is supplied in a documented product form, that storage information is available, and that the supplier avoids consumer-style claims.

When a technical procurement team evaluates where to buy CJC-1295 No DAC, the review should start with documentation rather than promotional language. The key question is whether the product record supports identity testing, purity review, lot number matching, and laboratory recordkeeping. Analytical chemistry literature supports the use of chromatographic and mass-spectrometric approaches for peptide characterization, but the method listed on a COA must be reviewed in relation to the specific batch and product identity [10] [11].

The safe expanded intent is buy CJC-1295 No DAC online for laboratory research. That intent should lead to a documentation review that includes RUO labeling, CJC-1295 No DAC purity documentation, CJC-1295 No DAC identity testing, storage records, lot traceability, and supplier transparency. It should not lead to personal-use instructions, medical advice, or claims about expected outcomes.

Research Procurement Checklist for CJC-1295 No DAC

  • Verify that CJC-1295 No DAC is labeled for research use only.
  • Review the batch-specific certificate of analysis before procurement.
  • Confirm that the CJC-1295 No DAC COA includes purity and identity documentation.
  • Check whether HPLC, LC-MS, mass spectrometry, or another analytical method is listed.
  • Compare the product name, lot number, product form, and documentation for consistency.
  • Assess whether the supplier avoids dosing, injection, therapeutic, or human-use claims.
  • Document storage and handling information in laboratory records.
  • Evaluate whether the lyophilized powder form matches the needs of the research workflow.
  • Confirm that the product is not marketed for human or animal consumption.

CJC-1295 No DAC Quality Signals to Review Before Buying Online

Before researchers buy CJC-1295 No DAC online, they should evaluate the source through documentation-based quality signals. Strong RUO procurement review considers whether the supplier provides batch-specific COA access, whether the label and COA match, whether analytical methods are described, and whether the product page stays within research-use-only boundaries.

Evaluation Area What Researchers Should Review Why It Matters for RUO Procurement
RUO labeling Confirm the product is clearly labeled for research use only Helps separate research procurement from human-use positioning
COA availability Review batch-specific certificate of analysis Supports lot-level documentation and quality review
Purity data Look for analytical support for the stated purity Helps evaluate material consistency
Identity testing Review HPLC, LC-MS, mass spectrometry, or related identity data Helps confirm the material matches the listed compound
Lot traceability Match lot numbers across product and documentation Supports research recordkeeping
Product form Confirm whether the material is supplied as lyophilized powder or another documented form Supports laboratory planning
Storage information Review storage and handling documentation Helps maintain material integrity in laboratory settings
Supplier language Confirm the supplier avoids dosing, therapeutic, or personal-use claims Supports research-use-only positioning

COA, Purity, and Identity Documentation

The certificate of analysis should be reviewed as a batch-specific document, not as a generic quality statement. For CJC-1295 No DAC supplier documentation, researchers should look for the compound name, lot number, test date, stated purity percentage, testing method, identity confirmation, molecular weight where relevant, sequence or formula information where relevant, chromatogram or mass data where available, product form, and storage documentation.

A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. HPLC is widely used for peptide analysis and purification, while mass spectrometry is commonly used to support synthetic peptide characterization [10] [11]. Liquid chromatography-high resolution mass spectrometry has also been discussed for peptide drug quality-control contexts, which underscores why method information matters in documentation review [12].

Impurity identification and value assignment for peptides can require more than a single purity number, especially when the review includes chromatographic behavior, high-resolution mass data, and method conditions [13]. USP chromatography guidance describes core chromatography concepts and system suitability considerations relevant to method review [14]. FDA and ICH analytical guidance documents also emphasize method validation, analytical procedure development, and documentation principles for identity, quality, purity, and method fitness [15] [16] [17].

flowchart TD A[Receive product and COA] --> B{RUO labeling present?} B -- No --> C[Flag procurement gap] B -- Yes --> D{Lot number matches across label and COA?} D -- No --> E[Request batch-specific documentation] D -- Yes --> F{Identity supported by analytical method?} F -- No --> G[Request HPLC, LC-MS, or equivalent] F -- Yes --> H[Proceed to laboratory documentation and storage]

Laboratories may also consider the competence and documentation practices of testing providers. ISO/IEC 17025 is an international standard for testing and calibration laboratory competence, impartiality, and consistent operation [18]. Storage and stability information should be recorded because stability guidance frameworks emphasize the role of storage conditions and time-dependent quality review in material management [19].

Research Literature Context

CJC-1295 appears in research literature related to GHRH analog design, receptor-pathway evaluation, analytical identification, and controlled study settings. The DAC-containing form of CJC-1295 has been examined in preclinical and clinical pharmacology literature, including studies on receptor activation, endocrine-axis measurements, and serum protein profile observations [4] [20] [21].

Published clinical literature should not be interpreted as use guidance for RUO materials. Those papers are outside the scope of RUO product procurement and do not establish instructions, outcomes, or intended use for CJC-1295 No DAC research material. The procurement question remains documentary: whether the supplier provides RUO labeling, a batch-specific COA, CJC-1295 No DAC purity documentation, identity information, storage guidance, and lot traceability.

Other literature has examined pulsatile endocrine measurements during continuous stimulation by CJC-1295, and a mouse model study evaluated a long-acting GHRH analog in a defined research setting [22] [23]. These publications provide scientific context only. They should not be converted into product-use claims, personal-use language, or assumptions about the No DAC material form.

Analytical literature is especially relevant for RUO procurement because it shows how peptide identity can be investigated. One report identified CJC-1295 in an unknown pharmaceutical preparation by analytical methods, while another described qualitative identification of growth hormone-releasing hormones in human plasma using immunoaffinity purification and LC-HRMS/MS [24] [25]. These sources support the importance of identity-focused analytical review, not any claim about use of an RUO material.

Evidence Landscape

Research Area What Literature Examines Evidence Type RUO Interpretation
Compound identity Molecular structure, formula, classification, and product-name distinctions Database / analytical Supports identification, not product-use claims
Pathway or category context GHRH receptor pathway, peptide analog literature, and receptor signaling models Review / in vitro / preclinical Useful for research context, not therapeutic claims
Analytical testing Purity, identity, impurity review, and batch verification HPLC / LC-MS / mass spectrometry / COA Supports documentation review
Storage and stability Material form, storage conditions, and handling records Laboratory documentation Supports research workflow planning

Claim Boundary Table

Research-Safe Statement Why It Is Acceptable Non-Compliant Version to Avoid
“CJC-1295 No DAC is discussed in published research related to GHRH analog and receptor-pathway context.” Describes literature context without making a product claim “CJC-1295 No DAC helps with a human outcome.”
“Researchers should review COA and identity data before procurement.” Focuses on documentation and quality review “Users should buy CJC-1295 No DAC for results.”
“Pure Lab Peptides supplies CJC-1295 No DAC as a research-use-only material.” Clarifies intended use “Pure Lab Peptides supplies CJC-1295 No DAC for therapy.”
“The phrase buy CJC-1295 No DAC online is addressed as research procurement intent.” Qualifies commercial search intent “Buy CJC-1295 No DAC online for personal use.”
“Pathway relevance in published literature does not establish product-use guidance for RUO materials.” Separates scientific context from supplier claims “Pathway research proves expected product effects.”

How Pure Lab Peptides Presents CJC-1295 No DAC

Pure Lab Peptides presents CJC-1295 No DAC 5mg as a research-use-only material for qualified laboratory procurement. The product is supplied as lyophilized powder, carries an ≥99% purity claim, and has batch-specific COA documentation available for review. Researchers should evaluate the product page, label information, COA, product form, storage and handling documentation, and lot-level traceability together.

Review the Pure Lab Peptides CJC-1295 No DAC research-use-only product page for RUO labeling, product details, purity information, and batch-specific documentation. Researchers comparing multiple RUO materials can also review the Pure Lab Peptides research peptide collection, supplier information in the Pure Lab Peptides blog resources, and procurement-policy information on the shipping and returns page.

Supplier transparency means the product record should help a laboratory buyer answer practical questions: What is the exact product name? What is the documented product form? Is the COA batch-specific? Does the lot number match? Is analytical support provided for purity and identity? Does the supplier maintain research-use-only positioning without consumer-style claims?

Common Misunderstandings About Buying CJC-1295 No DAC Online

Misunderstanding: “Buy CJC-1295 No DAC online” means personal use

Buy CJC-1295 No DAC online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, storage records, and supplier transparency.

Misunderstanding: Published literature equals product-use guidance

Published literature may describe GHRH analogs, receptor-pathway models, or analytical identification methods, but it does not create instructions for an RUO material. Research literature related to CJC-1295 No DAC supplier evaluation should be used as scientific context, not as a basis for product-use claims.

Misunderstanding: A purity percentage alone proves identity

A stated purity percentage is only one part of CJC-1295 No DAC purity documentation. Researchers should also review identity testing, analytical method notes, lot number, product name consistency, product form, and any available chromatographic or mass-spectrometric data before completing procurement records.

Misunderstanding: COA documentation does not need to be batch-specific

For RUO procurement, a generic quality statement is weaker than a batch-specific COA. Researchers should match the certificate of analysis to the product label and lot number so the CJC-1295 No DAC COA supports lot-level traceability and laboratory recordkeeping.

Misunderstanding: Pathway relevance equals a product claim

GHRH pathway literature can help researchers understand scientific context, but pathway relevance does not establish an RUO product claim. Pathway relevance in published literature does not establish product-use guidance for RUO materials.

Misunderstanding: Supplier claims can replace analytical documentation

Supplier statements should not replace CJC-1295 No DAC identity testing, batch-specific COA review, and lot traceability. A compliant RUO procurement review prioritizes documentation, analytical support, and labeling consistency over promotional language.

FAQs About Buying CJC-1295 No DAC Online for Research

Where can researchers buy CJC-1295 No DAC online for laboratory research?

Researchers can buy CJC-1295 No DAC online for laboratory research by selecting an RUO supplier that provides clear research-use-only labeling, batch-specific COA access, purity documentation, identity information, storage guidance, and lot traceability. Pure Lab Peptides provides a CJC-1295 No DAC 5mg product page for research procurement review.

What should researchers check before buying CJC-1295 No DAC online?

Before buying CJC-1295 No DAC online, researchers should check the product name, RUO label, lot number, batch-specific COA, stated purity, identity testing method, product form, storage documentation, and supplier language. The review should confirm that the supplier frames the material as research-use-only and avoids consumer-use positioning.

Why does a COA matter when buying CJC-1295 No DAC?

A COA matters when buying CJC-1295 No DAC because it provides batch-level documentation for the material under review. A useful CJC-1295 No DAC COA should support review of purity, identity, method, lot number, product name consistency, and product form. Researchers should keep the COA with laboratory procurement records.

Is CJC-1295 No DAC intended for human or animal consumption?

CJC-1295 No DAC discussed here is a research-use-only laboratory material and is not intended for human or animal consumption. The article addresses research procurement, documentation review, COA evaluation, supplier transparency, and laboratory recordkeeping. It does not provide personal-use guidance or product-use instructions.

What does research use only mean for CJC-1295 No DAC?

Research use only means CJC-1295 No DAC is positioned for controlled laboratory research workflows, documentation review, and compound characterization. RUO labeling separates laboratory procurement from consumer, therapeutic, diagnostic, or veterinary positioning. Researchers should evaluate the label, COA, purity documentation, identity data, and storage information.

How should published literature about CJC-1295 No DAC be interpreted?

Published literature about CJC-1295, related GHRH analogs, or receptor-pathway research should be interpreted as scientific context only. It should not be treated as product-use guidance for CJC-1295 No DAC research-use-only material. Laboratory buyers should focus on product identity, COA documentation, purity support, and lot traceability.

Next Steps

Qualified researchers evaluating CJC-1295 No DAC should review product labeling, COA status, identity documentation, purity information, storage guidance, and supplier transparency before selecting any research-use-only material. Review the CJC-1295 No DAC product page for RUO labeling, purity information, and available batch-specific documentation.

References

  1. U.S. Food and Drug Administration. “Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only.” FDA Guidance Document. 2013. fda.gov/regulatory-information/search-fda-guidance-documents/distribution-in-vitro-diagnostic-products-labeled-research-use-only-or-investigational-use-only
  2. National Center for Biotechnology Information. “CJC1295 Without DAC.” PubChem Compound Summary. 2026. pubchem.ncbi.nlm.nih.gov/compound/CJC1295-Without-DAC
  3. National Center for Biotechnology Information. “Cjc 1295.” PubChem Compound Summary. 2026. pubchem.ncbi.nlm.nih.gov/compound/Cjc-1295
  4. Jette L, et al. “Human Growth Hormone-Releasing Factor (hGRF)1-29-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GRF Analog.” Endocrinology. 2005. doi.org/10.1210/en.2004-1286
  5. Gaylinn BD. “Growth hormone releasing hormone receptor.” Receptors and Channels. 2002. doi.org/10.3109/10606820213679
  6. Lin-Su K, Wajnrajch MP. “Growth Hormone Releasing Hormone (GHRH) and the GHRH Receptor.” Reviews in Endocrine and Metabolic Disorders. 2002. doi.org/10.1023/A:1020949507265
  7. UniProt Consortium. “GHRHR – Growth hormone-releasing hormone receptor – Homo sapiens.” UniProtKB. 2026. uniprot.org/uniprotkb/Q02643/entry
  8. UniProt Consortium. “GHRH – Somatoliberin – Homo sapiens.” UniProtKB. 2026. uniprot.org/uniprotkb/P01286/entry
  9. Zhou F, et al. “Structural basis for activation of the growth hormone-releasing hormone receptor.” Nature Communications. 2020. doi.org/10.1038/s41467-020-18945-0
  10. Mant CT, Chen Y, Yan Z, Popa TV, Kovacs JM, Mills JB, Tripet BP, Hodges RS. “HPLC Analysis and Purification of Peptides.” Methods in Molecular Biology. 2007. doi.org/10.1007/978-1-59745-430-8_1
  11. Prabhala BK, Mirza O, Hojrup P, Hansen PR. “Characterization of Synthetic Peptides by Mass Spectrometry.” Methods in Molecular Biology. 2015. doi.org/10.1007/978-1-4939-2999-3_9
  12. Zeng K, Geerlof-Vidavisky I, Gucinski A, Jiang X, Boyne MT 2nd. “Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control.” The AAPS Journal. 2015. doi.org/10.1208/s12248-015-9730-z
  13. Stoppacher N, Josephs RD, Daireaux A, Choteau T, Westwood SW, Wielgosz RI. “Impurity identification and determination for the peptide hormone angiotensin I by liquid chromatography-high-resolution tandem mass spectrometry and the metrological impact on value assignments by amino acid analysis.” Analytical and Bioanalytical Chemistry. 2013. doi.org/10.1007/s00216-013-6953-7
  14. United States Pharmacopeia. “<621> Chromatography.” USP General Chapter. 2021. usp.org/sites/default/files/usp/document/harmonization/gen-chapter/harmonization-november-2021-m99380.pdf
  15. U.S. Food and Drug Administration. “Analytical Procedures and Methods Validation for Drugs and Biologics.” FDA Guidance Document. 2015. fda.gov/regulatory-information/search-fda-guidance-documents/analytical-procedures-and-methods-validation-drugs-and-biologics
  16. U.S. Food and Drug Administration. “Q2(R2) Validation of Analytical Procedures.” FDA Guidance Document. 2024. fda.gov/regulatory-information/search-fda-guidance-documents/q2r2-validation-analytical-procedures
  17. U.S. Food and Drug Administration. “Q14 Analytical Procedure Development.” FDA Guidance Document. 2024. fda.gov/regulatory-information/search-fda-guidance-documents/q14-analytical-procedure-development
  18. International Organization for Standardization. “ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories.” ISO Standard. 2017. iso.org/standard/66912.html
  19. U.S. Food and Drug Administration. “Q1A(R2) Stability Testing of New Drug Substances and Products.” FDA Guidance Document. 2018. fda.gov/regulatory-information/search-fda-guidance-documents/q1ar2-stability-testing-new-drug-substances-and-products
  20. Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. “Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults.” The Journal of Clinical Endocrinology & Metabolism. 2006. doi.org/10.1210/jc.2005-1536
  21. Sackmann-Sala L, Ding J, Frohman LA, Kopchick JJ. “Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.” Growth Hormone & IGF Research. 2009. doi.org/10.1016/j.ghir.2009.03.001
  22. Ionescu M, et al. “Pulsatile Secretion of Growth Hormone (GH) Persists during Continuous Stimulation by CJC-1295, a Long-Acting GH-Releasing Hormone Analog.” The Journal of Clinical Endocrinology & Metabolism. 2006. doi.org/10.1210/jc.2006-1702
  23. Alba M, et al. “Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.” American Journal of Physiology-Endocrinology and Metabolism. 2006. doi.org/10.1152/ajpendo.00201.2006
  24. Henninge J, Pepaj M, Hullstein I, Hemmersbach P. “Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.” Drug Testing and Analysis. 2010. doi.org/10.1002/dta.233
  25. Knoop A, Thomas A, Fichant E, Delahaut P, Schanzer W, Thevis M. “Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS.” Analytical and Bioanalytical Chemistry. 2016. doi.org/10.1007/s00216-016-9377-3

Have Questions?

Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.

0